Clinical Trial Update: Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of GEN2 in adults with advanced solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• GEN2

Snippet

Sponsor: GenVivo, Inc. | Conditions: Solid Tumor, Adult | Phase 1 | Status: TERMINATED